Christoph H. Westphal, President and CEO at Flex Pharma, Inc. (FLKS), bought 22,300 shares at $12.66 ($283K) on 2016-05-31, disclosed to the SEC on 2016-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.68 | 17,300 | $219K | 77.6% |
| 2 | $12.66 | 5,000 | $63K | 22.4% |
| Total | $12.68 avg | 22,300 | $283K | 100% |
| Filing → |
| FLKS | BUY | 2016-11-08 | $51K | — | Filing → |
| FLKS | BUY | 2016-11-07 | $51K | — | Filing → |
| FLKS | BUY | 2016-06-24 | $30K | — | Filing → |